Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
11,796
-795
-6% -$170K 0.31% 75
2026
Q1
$2.78M Buy
12,591
+68
+0.5% +$16.6K 0.38% 71
2025
Q4
$3.17M Buy
12,523
+194
+2% +$48.7K 0.42% 67
2025
Q3
$3.05M Buy
12,329
+42
+0.3% +$10.1K 0.41% 64
2025
Q2
$2.95M Buy
12,287
+155
+1% +$36.1K 0.43% 63
2025
Q1
$2.75M Buy
12,132
+177
+1% +$38.9K 0.43% 67
2024
Q4
$2.46M Buy
11,955
+622
+5% +$136K 0.37% 68
2024
Q3
$2.75M Buy
11,333
+688
+6% +$161K 0.42% 63
2024
Q2
$2.34M Buy
10,645
+572
+6% +$124K 0.41% 64
2024
Q1
$2.26M Buy
10,073
+320
+3% +$72.2K 0.42% 63
2023
Q4
$2.14M Buy
9,753
+873
+10% +$185K 0.45% 57
2023
Q3
$1.95M Buy
8,880
+228
+3% +$51.6K 0.48% 56
2023
Q2
$1.95M Buy
8,652
+335
+4% +$67K 0.47% 60
2023
Q1
$1.59M Buy
8,317
+125
+2% +$24.2K 0.4% 67
2022
Q4
$1.51M Buy
8,192
+545
+7% +$95.8K 0.41% 66
2022
Q3
$1.27M Buy
+7,647
New +$1.56M 0.41% 70

Other funds holding STE

Colonial Trust's STE Position: Q2 2026 in Review

Colonial Trust reduced its Steris (STE) stake by 6.3% in Q2 2026, selling an estimated $170K and leaving 11,796 shares worth $2.48M. The position accounts for 0.31% of the portfolio, ranked #75.

Colonial Trust first reported a position in STE in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.17M in Q4 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Colonial Trust held 11,796 shares of Steris worth $2.48M as of Q2 2026.
  • Colonial Trust sold 795 Steris shares in Q2 2026, an estimated $170K.
  • Steris made up 0.31% of Colonial Trust's portfolio in Q2 2026, its #75 holding.
  • Colonial Trust first reported a position in Steris in Q3 2022 and has held it in 16 quarters since.
  • Colonial Trust's Steris position peaked at $3.17M in Q4 2025.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.